News

West Lebanon, NH –December 31, 2008: M2S Inc., a global provider of image management services for biopharmaceutical and medical device clinical trials, announced today that the company has acquired DXA Resource Group (DRG) of Westborough, Massachusetts.  Founded in 2002, DRG recognized the need for cost-effective and responsive DXA (Dual- Emission X-Ray Absorptiometry) clinical quality assurance, project management and data management services to support drug development.  DXA, a low-dose (1/10^th of traditional x-ray) imaging modality that measures bone mineral density and body mass composition, is increasingly utilized in clinical trials to assess the safety and effectiveness of drugs under development for osteoporosis, HIV, obesity, growth hormone deficiency, endometriosis, fibroids and Gaucher’s disease.

“DRG has integrated quality service with imaging data technology, which exactly fits into the M2S mission and clinical trials image management service offering.  The addition of DRG allows M2S to further expand our capabilities and therapeutic expertise, and meet the growing demand for image management services worldwide,” M2S CEO Wes Chapman said.

“Adding M2S high-speed image collection and trial management technologies to DRG’s proprietary quality system and data management, enables us to greatly increase our presence in the drug development market,” said Reta Rupich, President of DXA Resource Group.

About M2S, Inc.

M2S provides image and data management services for clinical trials sponsors in the biopharmaceutical and medical device industries, patient registry databases and is a recognized leader in 3-D endovascular treatment planning. For the past 10 years, M2S has managed, under protocol, millions of images from around the globe in various therapeutic areas and in all DICOM modalities.  For more information, visit www.m2s.com.

About DXA Resource Group 

DXA Resource group is a clinical trials service company focused on providing customer-centric, cost-effective quality assurance as well as data and project management for clinical trials involving Dual X-ray Absorptiometry (DXA) measurements.  For more information visit www.dxaresourcegroup.com or www.m2s.com.

West Lebanon, NH –November 7, 2008: M2S Inc., an industry leader in endovascular treatment planning and patient registries, announced today that the company has reached a new milestone, having processed over 150,000 radiographic scans for evaluation and surveillance of aortic aneurysms.  With each scan received, M2S evaluates approximately 1,000 images, pushing M2S’ total images received and processed to over 150 million.

From each scan, M2S provides 3D reconstruction, measurement and registry services to physicians across the country, providing more accuracy and efficiency for endovascular aortic aneurysm pre-operative planning and post-operative surveillance.  The pre- and post-operative analyses are posted to M2S’ PEMS® website, providing physicians 24/7 access to their patient data and images.  Utilizing the Preview® treatment planning software from M2S, physicians can also interactively view the 3D model, as well as virtually implant stent grafts onto the 3D model to further optimize the visualization of treatment.   

M2S provides image and data management services and registries for endovascular treatment planning and clinical trials. Their services are designed to improve health care and reduce the time and cost of clinical trials.  For the past 10 years, M2S has worked with many of the world’s leading academic centers, pharmaceutical companies, and medical device manufacturers, managing under protocol, millions of images from around the globe. 

West Lebanon, NH – January 8, 2008: M2S Inc., an industry leader in medical image management and analysis, announced today that it has entered into a partnership agreement with ResearchPoint Global (RPG), a joint-venture, full-service CRO with an established presence in nearly 70 countries. M2S provides superior image management, state-of-the-art 3D modeling, and cutting edge image analysis to the pharmaceutical, biotech, surgical, and medical device industries. The partnership with RPG is the next step in M2S’ international growth for its Clinical Trials Services division.

The partnership will provide M2S’ clinical trials clients with access to RPG’s integration of services, including inter- national regulatory support, patient recruitment, and site selection and management. In addition, the partnership will help M2S expand its rapidly growing business with offices, sites, and experienced personnel in over 70 countries, while supporting the global deployment of its proprietary image transfer technology.

M2S’s CEO, Wes Chapman, said, “We’re pleased to be a part of the RPG network. RPG delivers the highest standard of quality in customer service while continually seeking innovative and cost-effective solutions to their clients’ needs. This new partnership will allow clinical investigators working on a global level to focus more freely on what they do best, rather than on the art, science, and logistics of core lab image processing and management – which is what we do best. The global expansion of our technology and the extension of our services will serve our clients well and help secure our plans to become the preeminent image management company.”

President and CEO of ResearchPoint and founding partner of RPG, John Farinacci notes, “We are pleased to now offer our clients comprehensive imaging services to support their clinical trial objectives. The collaboration with M2S and the imaging capabilities they offer creates seamless delivery between clinical monitoring and imaging management ac- tivities. RPG will now be able to collect and manage image data, and support independent reviews, whether centralized, remote, regional or global. Imaging services will reside at each of our global locations to ensure security and real-time monitoring.”

M2S’s DICOM ArmorCarTM (DACTM) image transfer technology has revolutionized the way medical images are trans- ported between sites, core labs, and clinical trial sponsors. The DACTM transfers image data securely in their original digital DICOM format for immediate, real-time QC assessment and query generation/resolution. In addition to its pres- ervation of data integrity, the DACTM provides incredible time savings and eliminates the immense costs associated with storing data on CDs and shipping them via courier, a standard practice in the industry today. The DAC is the first system designed specifically to address these significant issues, and the expansion of its global integration will allow clinical trial sponsors to utilize its power to manage their large international trials more efficiently and cost-effectively than ever before. DACs have already been installed and implemented in over 250 institutions in the U.S.A., as well as a growing number in Europe, South America, and Asia.

About M2S
M2S is a pioneer and leader in imaging core lab services and data management technology for clinical trials. For the past 15 years the company has worked with many of the world’s leading academic centers, managing, under protocol, over 25 million images from around the globe. M2S develops image-based systems and protocols that reduce time, costs and uncertainty for the healthcare discovery and delivery community.

About ResearchPoint Global
ResearchPoint Global is a joint venture comprised of global CROs and technology service providers. ResearchPoint Global (RPG) has 14 development partners and maintains a presence in nearly 70 countries. Each of these companies has a customer-centric focus and track record of success with pharmaceutical, biotechnology and medical device companies. The ResearchPoint Global team uses a continuum model of integrated clinical develop- ment services to expedite product development and improve the outsourcing experience for customers and investigators.

David H. Deaton, M.D., Associate Professor of Surgery and Chief of Endovascular Surgery at Georgetown University Hospital, has published an article entitled "Aortic Arch Reconstruction, Synergy of Open and Endovascular Techniques" in the October 2007 issue of Endovascular Today. Dr. Deaton's article includes case study information on the use of M2S image management tools. To download a pdf of the article, click here.